Key Decisions and Approvals

The Board of Directors meeting, held from 04:30 P.M. to 05:50 P.M. (IST) on August 10, 2026, approved the following:

1. Unaudited Financial Results: Approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the Limited Review Report of the Statutory Auditors.

2. 43rd Annual General Meeting (AGM): Finalized the date of the 43rd AGM to be held on Thursday, September 24, 2026, at 12:00 P.M. (IST) through video conferencing/other audio-visual means (VC/OAVM).

3. E-voting Cut-off Date: Fixed the cut-off date for e-voting as Thursday, September 17, 2026.

The Annual Report and Notice of the 43rd AGM will be shared with the stock exchanges and members within the prescribed timeline.

Consolidated Financial Results (Amount in ₹ Million)

For the Quarter Ended June 30, 2026 (Unaudited)

  • Revenue from operations: ₹1,102.42
  • Other income: ₹59.79
  • Total income: ₹1,162.21
  • Total expenses: ₹1,175.45
  • Profit before exceptional items and tax: ₹(13.24)
  • Exceptional items: Statutory impact of new labour codes (Refer Note 6) - Not applicable in current quarter (was ₹(2.21) million in Q4 FY2026)
  • Profit before tax: ₹(13.24)
  • Tax expense: ₹1.20
  • Current tax: ₹1.78
  • Tax in respect of earlier year: ₹(0.00)
  • Deferred tax charge/(credit): ₹(0.58)
  • Profit for the period: ₹(14.44)
  • Other comprehensive income: ₹0.58
  • Total comprehensive income for the period: ₹(13.86)
  • Paid-up equity share capital: ₹106.41
  • Other equity (including reserves): Not specified for current quarter
  • Earnings per equity share (face value of ₹2 each):
  • Basic: ₹(0.27)
  • Diluted: ₹(0.27)

Comparative Figures

  • Q4 FY2026 (March 31, 2026, Unaudited): Profit of ₹41.81 million
  • Q1 FY2026 (June 30, 2025, Unaudited): Profit of ₹17.83 million
  • FY2026 (March 31, 2026, Audited): Profit of ₹143.22 million

Standalone Financial Results (Amount in ₹ Million)

For the Quarter Ended June 30, 2026 (Unaudited)

  • Revenue from operations: ₹861.47
  • Other income: ₹67.54
  • Total income: ₹929.01
  • Total expenses: ₹918.79
  • Profit before exceptional items and tax: ₹9.22
  • Exceptional items: Statutory impact of new labour codes - Not applicable in current quarter (was ₹(2.21) million in Q4 FY2026)
  • Profit before tax: ₹9.22
  • Tax expense: ₹2.42
  • Current tax: ₹1.78
  • Deferred tax charge: ₹0.64
  • Profit for the period: ₹6.80
  • Other comprehensive income: ₹1.27
  • Total comprehensive income for the period: ₹8.07
  • Paid-up equity share capital: ₹106.41
  • Other equity (including reserves): Not specified for current quarter
  • Earnings per equity share (face value of ₹2 each):
  • Basic: ₹0.13
  • Diluted: ₹0.13

Comparative Figures

  • Q4 FY2026 (March 31, 2026, Unaudited): Profit of ₹54.64 million
  • Q1 FY2026 (June 30, 2025, Unaudited): Profit of ₹35.70 million
  • FY2026 (March 31, 2026, Audited): Profit of ₹226.58 million

Segment-wise Performance (Consolidated)

For the Quarter Ended June 30, 2026

  • India segment revenue: ₹861.14 million
  • Germany segment revenue: ₹241.28 million
  • Rest of the world segment revenue: ₹0.00 million
  • Total revenue: ₹1,102.42 million

Segment results before exceptional items, interest, tax and depreciation:

  • India: ₹294.35 million
  • Germany: ₹24.14 million
  • Rest of the world: ₹(1.88) million
  • Total: ₹316.61 million

Auditor's Review Report

Price Waterhouse Chartered Accountants LLP issued a review report with an unmodified conclusion on both consolidated and standalone financial results. The review was conducted in accordance with SRE 2410 issued by ICAI.

Key observations in consolidated review:

  • Financial information of one subsidiary (representing total income of ₹245.53 million, net profit of ₹4.16 million) was reviewed by other auditors with unmodified conclusions.
  • Financial information of two subsidiaries (representing total income of ₹15.66 million, net loss of ₹(17.71) million) was not reviewed by their auditors as they were not material to the Group.

Notes to Financial Statements

1. Consolidated Entities: Includes Tarsons Products Limited (Holding Company), Tarsons Life Science Pte. Ltd., Singapore (100% subsidiary), Nerbe plus GmbH & Co. KG, Germany (100% subsidiary), and Nerbe R&D GmbH, Germany (100% subsidiary).

2. New Labour Codes: Effective November 1, 2025, the Government of India consolidated multiple labour legislations into four Labour Codes. The Company had assessed and disclosed an incremental impact of ₹11.27 million in FY2026 financial results, primarily due to changes in the definition of wages and recognition of past service costs. The government is in the process of notifying related rules, and the exact quantification will be evaluated as per applicable accounting standards.

3. Managerial Remuneration: During FY2026, the Company paid excess remuneration of ₹1.67 million to its Managing Director, ₹20.51 million to its Whole Time Director, and ₹1.21 million to Other Directors, resulting in overall excess remuneration of ₹41.39 million. The Company is in the process of seeking approval for waiver of this excess remuneration through a special resolution in the ensuing general meeting.

4. Segment Reporting: The Company operates primarily in the business of manufacturing and selling plastic laboratory products and certain scientific instruments, which represents a single business segment. Geographical segments are reported as India, Germany, and Rest of the World.

Additional Information

The above intimations will be hosted on the company website at www.tarsons.com.